| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011.
|
Clin Infect Dis
|
2011
|
1.51
|
|
2
|
Regional distribution of wall thickness and failure properties of human abdominal aortic aneurysm.
|
J Biomech
|
2005
|
1.49
|
|
3
|
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
|
J Am Acad Dermatol
|
2002
|
1.39
|
|
4
|
Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.
|
Cancer Res
|
2004
|
1.01
|
|
5
|
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction.
|
Dermatol Surg
|
2016
|
0.94
|
|
6
|
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
|
Leuk Lymphoma
|
2012
|
0.92
|
|
7
|
A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring.
|
J Drugs Dermatol
|
2015
|
0.83
|
|
8
|
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
|
Clin Cancer Res
|
2013
|
0.83
|
|
9
|
Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium.
|
Vector Borne Zoonotic Dis
|
2013
|
0.81
|
|
10
|
Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.
|
BMC Pulm Med
|
2014
|
0.79
|
|
11
|
Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
|
J Clin Psychiatry
|
2007
|
0.79
|
|
12
|
Suicidal ideation in veterans receiving treatment for opiate dependence.
|
J Psychoactive Drugs
|
2006
|
0.77
|
|
13
|
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
|
Clin Pharmacokinet
|
2003
|
0.76
|
|
14
|
A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.
|
Mol Pharmacol
|
2004
|
0.76
|
|
15
|
Metabolic alkalosis and cystic fibrosis.
|
Chest
|
2002
|
0.76
|
|
16
|
Eosinophilia in refugees.
|
Clin Infect Dis
|
2006
|
0.75
|
|
17
|
Lost in translation.
|
Minn Med
|
2013
|
0.75
|